How are brain-computer interfaces expanding beyond single patients in 2025?

The answer

Brain-computer interface (BCI) technology crossed a major threshold in 2025 as clinical trial participation expanded from single-digit patients to dozens of people testing the safety and efficacy of brain implants. Companies including Neuralink, Synchron, and Blackrock Neurotech advanced trials allowing paralyzed individuals to control computers, phones, and robotic arms using only their thoughts. The technology works by detecting patterns of neural activity from implanted electrodes and translating them into digital commands in real time. Beyond restoring mobility, BCIs are being explored for treating depression, epilepsy, and chronic pain by directly modulating brain circuits. Researchers predict that by the end of the decade, BCIs could become as routine as cochlear implants.